Fitbone

Blog

Company Updates

Orthofix Announces More Than 5,000 Fitbone Intramedullary Limb-Lengthening Devices Implanted Worldwide to Date

March 7, 2023

As we head into the annual meeting of the American Academy of Orthopaedic Surgeons, we are proud to announce several…

Fitbone

Company Updates

Stronger Together: Building a Leading Global Spine and Orthopedics Company

October 11, 2022

Forward-Looking Statements  This communication contains statements which, to the extent they are not statements of historical or present fact, constitute…

Company Updates

Orthofix Announces a Strategic Partnership Agreement with CGBio

August 2, 2022

LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a…

Company Updates

FDA Approves AccelStim Bone Healing Therapy Device and Expands Orthofix’s Portfolio of Bone Growth Stimulation Solutions

May 4, 2022

LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the…

AccelStim Bone Healing Therapy

Company Updates

Orthofix Supports Medical and Relief Efforts in Ukraine

March 20, 2022

Orthofix is supporting the humanitarian efforts underway in Ukraine and neighboring countries through a $25,000 donation to the International Medical Corps. Inside Ukraine…